EDIT R&D to Revenue

Editas Medicine Inc · R&D to Revenue

EDIT logo

EDIT R&D to Revenue

Latest reported169.72%
EDIT Quarterly R&D/Revenue (0.00% → 169.72%)
High-resolution chart · PNG

EDIT r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Editas Medicine Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
169.7225%
100%
110.7635%
262.1636%
452.2359%
570.9103%
158.8387%
78,096.7213%
10,290.4483%
4,174.2731%
113.3907%
100%
1,031.486%
383.758%
795.563%
98,395.2381%
686.2465%
560.8625%
301.1709%
472.2446%
8,905.8047%
645.2839%
538.6111%
53.9711%
260.5545%
604.0538%
283.2058%
589.9688%
1,011.3734%
765.6839%
313.695%
120.1391%
443.8144%
542.3988%
720.589%
324.6737%
559.1863%
2,789.0029%
2,988.3073%
1,125.9875%
307.8512%
1,103.354%
735.6061%
574.6269%
4,360.479%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.